{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["20(7)"],"submitter":["Nguyen JMV"],"pubmed_abstract":["<h4>Background</h4>There is considerable variability in how older adults with cancer tolerate and recover from surgery and systemic treatments. A greater understanding of individual trajectories is crucial in guiding personalized treatment decisions. Frailty may explain these inter-individual differences. Despite emerging evidence on the association between perioperative frailty assessment and outcomes after noncardiac surgery, there is limited data in gynecologic oncology. A perioperative cardiovascular risk assessment, recommended by scientific guidelines, is widely adopted in noncardiac surgery, often as the only standardized perioperative risk stratification approach. While based on robust evidence on the association with cardiovascular complications and overall mortality, it might be "],"journal":["PloS one"],"pagination":["e0325651"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12303337"],"repository":["biostudies-literature"],"pubmed_title":["Frailty Assessment for Risk prediction in Gynecologic Oncology patients undergoing surgery and chemotherapy (FARGO) study protocol: Rationale and design of a multi-centre prospective cohort study."],"pmcid":["PMC12303337"],"pubmed_authors":["Borges FK","Patel A","Nguyen JMV","Miletic D","Pare G","Ofori S","Zigras T","Hogen L","Di Sante E","Devereaux PJ","Vincent J","Panus O","Chong M","Benitez YR","Marcucci M","Vicus D","Ramasundarahettige C","Nene S"],"additional_accession":[]},"is_claimable":false,"name":"Frailty Assessment for Risk prediction in Gynecologic Oncology patients undergoing surgery and chemotherapy (FARGO) study protocol: Rationale and design of a multi-centre prospective cohort study.","description":"<h4>Background</h4>There is considerable variability in how older adults with cancer tolerate and recover from surgery and systemic treatments. A greater understanding of individual trajectories is crucial in guiding personalized treatment decisions. Frailty may explain these inter-individual differences. Despite emerging evidence on the association between perioperative frailty assessment and outcomes after noncardiac surgery, there is limited data in gynecologic oncology. A perioperative cardiovascular risk assessment, recommended by scientific guidelines, is widely adopted in noncardiac surgery, often as the only standardized perioperative risk stratification approach. While based on robust evidence on the association with cardiovascular complications and overall mortality, it might be ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2026-03-16T08:51:56.309Z","creation":"2025-08-17T03:06:05.472Z"},"accession":"S-EPMC12303337","cross_references":{"pubmed":["40720507"],"doi":["10.1371/journal.pone.0325651"]}}